73 related articles for article (PubMed ID: 1821651)
1. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
2. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
5. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
Cavari S; Ruggiero M; Vannucchi S
Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
[TBL] [Abstract][Full Text] [Related]
7. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
8. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
10. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
11. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and secretion of recombinant protein--the product of v-sis oncogene in Saccharomyces cerevisiae cells].
Ratovitskiĭ EA; Rudenko AB; Vasinova NA; Kidgotko OV; Nisman BKh
Mol Gen Mikrobiol Virusol; 1990 May; (5):20-4. PubMed ID: 2199826
[TBL] [Abstract][Full Text] [Related]
13. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
14. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
15. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
16. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
17. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
Rapp UR; Troppmair J; Beck T; Birrer MJ
Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
Kim HR; Upadhyay S; Korsmeyer S; Deuel TF
J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979
[TBL] [Abstract][Full Text] [Related]
19. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]